TFPI2 and fatty liver disease: We obtained samples from five cases of nonfatty liver and five cases of fatty liver from clinically discarded livers, all of which underwent 8–24 h of CS before collection to confirm the changes in TFPI2 and CLIP1 molecules in human fatty liver (Fig. 7a and Supplementary Table 3).